Half Year Results 

Don’t sleep on Synthomer

Don’t sleep on Synthomer

Back in 2016, Synthomer (SYNT) embarked on a huge capital expenditure growth programme tasked with helping the Essex-based group to capitalise on the many structural drivers fuelling demand for its speciality chemicals. Efforts to boost manufacturing output, widen its scope via acquisitions, and improve the resilience of its raw materials supply chain triggered a steady 2 per cent rise in underlying operating profit at constant currencies at the halfway point.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now